【researchmap】
https://researchmap.jp/sugayam

<代表論文>

1. 1. Oka T, et al. CXCL17 attenuates imiquimod-induced psoriasis-like skin inflammation by recruiting myeloid-derived suppressor cells and regulatory T cells. J Immunol 198:3897-3908, 2017.
2. 2. Takahashi N, et al. Thymic stromal chemokine TSLP acts through Th2 cytokine production to induce cutaneous T cell lymphoma. Cancer Res76:6241-6252, 2016.
3. 3. Suga H, et al. Skin barrier dysfunction and low antimicrobial peptide expression in cutaneous T-cell lymphoma. Clin Cancer Res 20: 4339-4348, 2014.
4. 4. Suga H, et al. CXCR3 deficiency prolongs Th1-type contact hypersensitivity. J Immunol 190:6059-6070, 2013.
5. 5. Morimura S, et al. Interaction between CX3CL1 and CX3CR1 regulates vasculitis induced by immune complex deposition. Am J Pathol 182:1640-1647, 2013.
6. 6. Miyagaki T, et al. IL-22, but not IL-17, dominant environment in cutaneous T cell lymphoma. Clin Cancer Res 17: 7529-7538, 2011.
7. 7. Miyagaki T, et al. CCL11-CCR3 interactions promote survival of anaplastic large cell lymphoma cells via ERK1/2 activation. Cancer Res 71: 2056-2065, 2011.
8. 8. Sugaya M, et al. Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes. J Immunol 177:7665-7672, 2006.
9. 9. Sugaya M, et al. Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter. Blood 105: 2356-2363, 2005.
10. 10. Sugaya M, et al. HIV-infected Langerhans cells preferentially transmit virus to proliferating autologous CD4+ memory T cells located within Langerhans cell-T cell clusters. J Immunol 172:2219-2224, 2004.